Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane.

about

The (gradual) rise of memory inflation.Memory inflation following adenoviral vaccination depends on IL-21

P2860

Q52583252-246B85CD-6E74-4C1A-BA06-B83B41F4BAFD Q57065798-EBB88060-D762-403B-96E6-BCA1C017B8D3

P2860

Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane.

Item

http://www.wikidata.org/entity/Q47607706

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Chimpanzee adenoviral vectors ...... technology into the fast lane.

@en

Chimpanzee adenoviral vectors ...... technology into the fast lane.

@nl

type

Item

label

Chimpanzee adenoviral vectors ...... technology into the fast lane.

@en

Chimpanzee adenoviral vectors ...... technology into the fast lane.

@nl

prefLabel

Chimpanzee adenoviral vectors ...... technology into the fast lane.

@en

Chimpanzee adenoviral vectors ...... technology into the fast lane.

@nl

P1476

Chimpanzee adenoviral vectors ...... technology into the fast lane.

@en

P2093

Alessandra Vitelli

http://www.w3.org/2001/XMLSchema#string

Alfredo Nicosia

http://www.w3.org/2001/XMLSchema#string

Antonella Folgori

http://www.w3.org/2001/XMLSchema#string

Elisa Scarselli

http://www.w3.org/2001/XMLSchema#string

Stefania Capone

http://www.w3.org/2001/XMLSchema#string

Stefano Colloca

http://www.w3.org/2001/XMLSchema#string

P2860

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report

Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs

Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses

Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments

Inflammasome control of viral infection

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity

Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors

Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality

P304

1241-1252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14760584.2017.1394842

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29047309

http://www.w3.org/2001/XMLSchema#string

P921

Adenoviridae

Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane.

about

P2860

P2860

Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921